Joseph Miller
Chief Financial Officer
CFO
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Aurinia Pharmaceuticals Inc. (AUPH) | Former Chief Financial Officer | $526,988 | $2,102,747 |
| 2024 | Aurinia Pharmaceuticals Inc. (AUPH) | Former Chief Financial Officer | $500,701 | $2,297,805 |
| 2023 | Aurinia Pharmaceuticals Inc. (AUPH) | Former Chief Financial Officer | $500,701 | $3,976,937 |
| 2020 | Avalo Therapeutics, Inc. (AVTX) | Former Chief Financial Officer, former principal financial officer, and former principal executive officer | $116,748 | $232,269 |
| 2019 | Avalo Therapeutics, Inc. (AVTX) | Former Chief Financial Officer, former principal financial officer, and former principal executive officer | $356,000 | $1,170,598 |
| 2018 | Avalo Therapeutics, Inc. (AVTX) | Former Chief Financial Officer, former Principal Financial Officer, and former Principal Executive Officer | $153,600 | $672,985 |
Earnings-call appearances
-
Aurinia Pharmaceuticals Inc. Q3 FY2025 Earnings Call2025-11-04
Aurinia Pharmaceuticals Inc. (AUPH)
-
Aurinia Pharmaceuticals Inc. Q2 FY2025 Earnings Call2025-07-31
Aurinia Pharmaceuticals Inc. (AUPH)
-
Aurinia Pharmaceuticals Inc. Q1 FY2024 Earnings Call2024-03-31
Aurinia Pharmaceuticals Inc. (AUPH)
-
Aurinia Pharmaceuticals Inc. Q4 FY2022 Earnings Call2023-02-28
Aurinia Pharmaceuticals Inc. (AUPH)
-
Aurinia Pharmaceuticals Inc. Q3 FY2020 Earnings Call2020-09-30
Aurinia Pharmaceuticals Inc. (AUPH)
-
Aurinia Pharmaceuticals Inc. Q1 FY2020 Earnings Call2020-03-31
Aurinia Pharmaceuticals Inc. (AUPH)